Functionalized 3-benzylidene-indolin-2-ones: inducers of NAD(P)H-quinone oxidoreductase 1 (NQO1) with antiproliferative activity.
暂无分享,去创建一个
Wei Zhang | Mei-Lin Go | Wei Zhang | M. Go
[1] J. Pezzuto,et al. Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage. , 1995, Carcinogenesis.
[2] J. Pezzuto,et al. Characterization of Natural Product Chemopreventive Agents , 2005 .
[3] L. Landi,et al. DT-Diaphorase maintains the reduced state of ubiquinones in lipid vesicles thereby promoting their antioxidant function. , 1997, Free radical biology & medicine.
[4] D. Liebler,et al. The Reduction of α-Tocopherolquinone by Human NAD(P)H:Quinone Oxidoreductase: The Role of α-Tocopherolhydroquinone as a Cellular Antioxidant , 1997 .
[5] A. Jaiswal,et al. NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20s proteasomal degradation leading to stabilization and activation of p53. , 2007, Cancer research.
[6] Eiichi Akaho,et al. Synthesis and anti-tyrosine kinase activity of 3-(substituted-benzylidene)-1, 3-dihydro-indolin derivatives: investigation of their role against p60c-Src receptor tyrosine kinase with the application of receptor docking studies. , 2005, Farmaco.
[7] A. Kong,et al. Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects. , 2005, Trends in pharmacological sciences.
[8] Xifu Liang,et al. Indolin-2-ones with high in vivo efficacy in a model for multiple sclerosis. , 2005, Journal of medicinal chemistry.
[9] Paul Talalay,et al. Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[10] M. Kunkel,et al. Antitumor activity of substituted E-3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones1. , 2006, Journal of medicinal chemistry.
[11] P. Nioi,et al. Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. , 2004, Mutation research.
[12] M. Paquet,et al. Lower induction of p53 and decreased apoptosis in NQO1-null mice lead to increased sensitivity to chemical-induced skin carcinogenesis. , 2005, Cancer research.
[13] Bharat B. Aggarwal,et al. Genetic Deletion of NAD(P)H:Quinone Oxidoreductase 1 Abrogates Activation of Nuclear Factor-κB, IκBα Kinase, c-Jun N-terminal Kinase, Akt, p38, and p44/42 Mitogen-activated Protein Kinases and Potentiates Apoptosis* , 2006, Journal of Biological Chemistry.
[14] Gerald Batist,et al. Transcriptional Regulation of NF-E2 p45-related Factor (NRF2) Expression by the Aryl Hydrocarbon Receptor-Xenobiotic Response Element Signaling Pathway , 2005, Journal of Biological Chemistry.
[15] A. Dinkova-Kostova,et al. Chemoprotective properties of phenylpropenoids, bis(benzylidene)cycloalkanones, and related Michael reaction acceptors: correlation of potencies as phase 2 enzyme inducers and radical scavengers. , 1998, Journal of medicinal chemistry.
[16] C. Wolf,et al. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. , 2001, Cancer research.
[17] D. Brauze. Comparison of the induction of a 4S β-naphthoflavone-binding protein, cytochrome P450 1A1 and NAD(P)H:quinone oxidoreductase in β-naphthoflavone-treated rats , 2004 .
[18] U. Burger,et al. Cyclization Studies with N-Mannich bases of 2-substituted indoles , 1989 .
[19] A. Dinkova-Kostova,et al. Role of nicotinamide quinone oxidoreductase 1 (NQO1) in protection against toxicity of electrophiles and reactive oxygen intermediates. , 2004, Methods in enzymology.
[20] G. Mcmahon,et al. Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases. , 1998, Journal of medicinal chemistry.
[21] A. Santamaria,et al. Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: a screening assay for anticarcinogenic enzyme inducers. , 1988, Analytical biochemistry.
[22] P. Righetti,et al. (Z)- and (E)-Arylidene-1,3-dihydroindol-2-ones: configuration, conformation, and infrared carbonyl stretching frequencies , 1984 .
[23] C. Papageorgiou,et al. Acid‐Catalyzed Rearrangements for a Diastereoselective Entry into a New Fused Hexacyclic Heterocycle: (5RS,7aRS,12RS,14aRS,)‐4,5,7a,11,12,14,14a‐octahydro‐5,12‐dimethyl‐diindolo [1,7‐bc: 1′,7′‐gh][2,6] naphthyridine , 1988 .
[24] R. Cole,et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[25] H. Ashida,et al. Antagonistic and agonistic effects of indigoids on the transformation of an aryl hydrocarbon receptor. , 2008, Archives of biochemistry and biophysics.
[26] A. Andreani,et al. Synthesis and cardiotonic activity of 2-indolinones , 1990 .
[27] W. Baer-Dubowska,et al. The effect of aryl hydrocarbon receptor ligands on the expression of AhR, AhRR, ARNT, Hif1alpha, CYP1A1 and NQO1 genes in rat liver. , 2006, Toxicology letters.
[28] R. Barouki,et al. Regulation of NAD(P)H:quinone oxidoreductase 1 gene expression by CYP1A1 activity. , 2004, Molecular pharmacology.
[29] Michael O. Kelleher,et al. The cancer chemopreventive actions of phytochemicals derived from glucosinolates , 2008, European journal of nutrition.
[30] R. Mayer,et al. Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. , 1974, Drug metabolism and disposition: the biological fate of chemicals.
[31] D A Scudiero,et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. , 1988, Cancer research.
[32] J. Hayes,et al. Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinone oxidoreductase in rat liver. , 2000, Cancer research.
[33] P. N. Craig,et al. Interdependence between physical parameters and selection of substituent groups for correlation studies. , 1971, Journal of medicinal chemistry.
[34] Y. Surh,et al. Cancer chemoprevention with dietary phytochemicals , 2003, Nature Reviews Cancer.
[35] P. O'Brien,et al. Coenzyme Q cytoprotective mechanisms. , 2004, Methods in enzymology.
[36] G L Snyder,et al. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? , 2001, The Journal of biological chemistry.
[37] Y. Kan,et al. Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduc , 2004, The Biochemical journal.
[38] D. Roop,et al. NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis. , 2000, Cancer research.
[39] K. Bock,et al. Activation of coupled Ah receptor and Nrf2 gene batteries by dietary phytochemicals in relation to chemoprevention. , 2006, Biochemical pharmacology.
[40] P. Talalay,et al. Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. , 1988, Cancer research.
[41] A. Fornace,et al. Cellular responses to oxidative stress: the [Ah] gene battery as a paradigm. , 1990, Environmental health perspectives.
[42] Ping Chen,et al. Structure-activity-relationship studies of conformationally restricted analogs of combretastatin A-4 derived from SU5416. , 2006, Bioorganic & medicinal chemistry.
[43] D. Ross,et al. NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. , 2004, Methods in enzymology.
[44] M. Massiah,et al. Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[45] K. Bock,et al. Coordinate regulation of Phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2. , 2007, Biochemical pharmacology.
[46] J. Pezzuto,et al. Quinone reductase induction as a biomarker for cancer chemoprevention. , 2006, Journal of natural products.
[47] Shigetoshi Takahashi,et al. Rhodium-catalyzed carbonylation of 2-alkynylaniline: Syntheses of 1,3-dihydroindol-2-ones , 1995 .
[48] A. Jaiswal,et al. Antioxidant response element. , 1994, Biochemical pharmacology.
[49] Y. Fujii‐Kuriyama,et al. Ah receptor, a novel ligand-activated transcription factor. , 1997, Journal of biochemistry.